Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In forensic toxicology, a marker of street heroin use is urgent especially in the absence of urinary 6-monoacetylmorphine. ATM4G, the Glucuronide of Acetylated product of Thebaine compound 4 Metabolite (ATM4), arising from byproducts of street heroin synthesis has been considered as a useful marker in some European studies. However, whether ATM4G is a universal marker particularly in Southeast Asia due to 'street' heroin with high purity, it's still unclear. To investigate putative markers for different regions, ATM4G and other metabolites including the Acetylated product of Thebaine compound 3 Metabolite (ATM3) and thebaol, also originated from thebaine were detected in 552 urine samples from heroin users in Taiwan. Results were compared with that from samples collected in the UK and Germany. Only a sulfo-conjugate of ATM4, ATM4S, was detected in 28 Taiwanese users using a sensitive MS method whilst out of 351 samples from the UK and Germany, ATM4G was present in 91. Thebaol-glucuronide was first time detected in 118. No markers were detected in urine following herbal medicine use or poppy seed ingestion. The presence of ATM4S/ATM4G might be affected by ethnicities and heroin supplied in regions. Thebaol-glucuronide is another putative marker with ATM4G and ATM4S for street heroin use.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yrtph.2021.105097DOI Listing

Publication Analysis

Top Keywords

street heroin
12
heroin
8
acetylated product
8
product thebaine
8
thebaine compound
8
compound metabolite
8
atm4g
5
proposed approach
4
approach confirm
4
confirm heroin
4

Similar Publications

Comparison of Office for National Statistics (ONS) and National Programme on Substance Use Mortality (NPSUM) data suggests that opioid-related deaths in England & Wales have been systematically underestimated.

Int J Drug Policy

August 2025

Centre for Pharmaceutical Medicine Research, Institute of Pharmaceutical Science, King's College London, 150 Stamford Street, London SE1 9NH, UK; National Programme on Substance Use Mortality, London, UK. Electronic address:

Background: In 2023, the Office for National Statistics (ONS) attributed 46.8 % of fatal drug poisonings in England and Wales to opioids. However, this figure likely underrepresents the true scale of opioid-related deaths, as ONS cannot identify opioid involvement when ambiguous causes (e.

View Article and Find Full Text PDF

Objective: To synthesize and determine the relative effectiveness of diverse opioid agonist treatment (OAT) medications, including injectables, for opioid use disorder (OUD).

Methods: We searched EMBASE, PubMed, and CENTRAL for Randomised Controlled Trials (RCTs) (CRD42018109469) and previously published systematic reviews of head-to-head trials of OAT medications. The primary outcome was treatment retention, and secondary outcomes included days of opioid use, days of cocaine use, and proportion of participants involved in criminalized activities.

View Article and Find Full Text PDF

Aim: Chronic opioid exposure (COE) is linked to adverse health outcomes, but its relationship with cardiovascular disease (CVD) remains unclear. This systematic review and meta-analysis aimed to summarise published evidence on CVD risk associated with COE, including prescription opioids, opium use, and opioid use disorder (OUD).

Methods: Following PRISMA guidelines and PROSPERO registration (CRD42024573206), we searched multiple databases for relevant human studies reporting associations between COE and CVD.

View Article and Find Full Text PDF

Introduction: Non-prescribed use of opioid agonist treatment (OAT) medications is a public health concern. This study analyses the prevalence of non-prescribed use and non-fatal overdoses in Norway in 2013 and 2023, a period marked by an increasingly flexible OAT regimen, and examines associations between non-prescribed use and non-fatal overdoses.

Methods: Cross-sectional surveys with two convenience samples (n1=611 in 2013, n2=523 in 2023) of street-recruited individuals, who reported recent use of opioids and/or stimulants but were not currently enrolled in OAT, were employed.

View Article and Find Full Text PDF